Chinese Professional Diltiazem - DILTIAZEM CAS NO: 42399-41-7 – Guanlang Detail:
We are one of the leading Diltiazem hcl manufacturers in china with Cas no: 42399-41-7 , welcome for enquiry for our Diltiazem hcl price. If you want to find Diltiazem hcl factory in china,come to us.
Diltiazem TDS
Appearance | white powder |
Assay | 99% min |
Density | 1.26 g/cm3 |
Boiling point | 594.4ºC at 760 mmHg |
Melting point | 212 °C |
Flash point | 313.3ºC |
Storage condition | Seal and store in a dry place |
Diltiazem Pharmacology and toxicology:
1.This product is a non-dihydropyridine calcium channel blocker. Its effect is related to the inhibition of calcium influx during depolarizing of myocardium and vascular smooth muscle.
2.This product can effectively dilate the epicardial and subendocardial coronary arteries, relieve spontaneous angina or angina caused by ergoxin induced coronary artery spasm; Reduces myocardial oxygen demand, increases exercise tolerance, and relieves exertional angina by slowing the heart rate and lowering blood pressure.
3.This product relaxes the vascular smooth muscle, decreases the peripheral vascular resistance and lowers the blood pressure. The extent of hypotension is related to the degree of hypertension, and the normal blood pressure only makes the blood pressure drop slightly.
4.This product has negative inotropic effect and can slow down the conduction of sinoatrial node and atrioventricular node.
Diltiazem Usage
This product is a calcium channel blocker, which can relieve angina pectoris, reduce blood pressure, have negative inotropic effect, and slow down the conduction of sinoatrial node and atrioventricular node.
Diltiazem is a new type of calcium antagonist, which can be used to treat supraventricular dysrhythmia, angina pectoris and hypertension in the elderly.
Used for treatment of hypertensive Patients.
Diltiazem Contraindication:
1.Allergic to Diltiazem or other calcium channel blockers.
2.Severe hypotension or cardiogenic shock.
3.Acute myocardial infarction with pulmonary congestion.
4.Contraindicated in pregnancy
Diltiazem Adverse reaction:
Common: edema, headache, nausea, dizziness, rash, weakness
Diltiazem Packaging and Shipping:
Packaging: 1kg/Aluminum Foil Bag, 25kg/drum
Shipping: 7-15 days for big orders
Diltiazem Sample order
Available
About our Company:
Our Exhibition:
Our ISO Certificate:
Product detail pictures:
Related Product Guide:
Cooperation
With the "Client-Oriented" business philosophy, a rigorous quality control system, advanced manufacturing equipment and a strong R&D team, we always provide high quality products, excellent services and competitive prices for Chinese Professional Diltiazem - DILTIAZEM CAS NO: 42399-41-7 – Guanlang, The product will supply to all over the world, such as: Malta, Anguilla, Georgia, Our company will adhere to "Quality first, , perfection forever, people-oriented , technology innovation"business philosophy. Hard work to keep making progress, innovation in the industry, make every effort to first-class enterprise. We try our best to build the scientific management model, to learn abundant professional knowledge, to develop advanced production equipment and production process , to create the first-call quality products, reasonable price , high quality of service , quick delivery , to give you create new value .
Hebei Guanlang Biotechnology Co., Ltd. belongs to Guanlang Group, which was founded in 2007 , located in Shijiazhuang city which is the capital of Hebei Province and hub sector among Beijing Tianjin and Hebei and has advantage of convenient transportation . Our company is a modern high-tech chemical enterprise with Research & Development, production and sales.We have our own factory and lab,also offer customized synthesis service for our customers.
By Eunice from South Korea - 2017.09.22 11:32
The customer service staff is very patient and has a positive and progressive attitude to our interest, so that we can have a comprehensive understanding of the product and finally we reached an agreement, thanks!
By Jean Ascher from Kenya - 2018.08.12 12:27